Trials / Completed
CompletedNCT00245934
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
Observational Study With Enbrel in Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the incidence of adverse events for patients with rheumatoid arthritis treated with Enbrel under usual care settings. In addition, differences in injection site reactions based on whether health care professionals or patients administer Enbrel will be assessed and evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enbrel |
Timeline
- Start date
- 2003-06-01
- Completion
- 2005-07-01
- First posted
- 2005-10-28
- Last updated
- 2007-12-14
Source: ClinicalTrials.gov record NCT00245934. Inclusion in this directory is not an endorsement.